Ss Innovations International Inc. · NASDAQ:SSII

Ss Innovations International — Investor Presentation (October 2026)

30 slides from Ss Innovations International's investor presentation, October 2026

  1. Slide 1: We Build Advanced, Affordable and Accessible Surgical Robotic Solutions

    We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2026 Nasdaq: SSII

  2. Slide 2: Disclaimers

    Disclaimers No Offering of Securities No offer is made by this Company Presentation (this “Presentation”) to invest in SS Innovations International, Inc. (the “Company”) or to purchase any of its securities. Any offer to make such an investment or purchase and such investment or purchase will be mad

  3. Slide 3: Our Vision

    Our Vision To continuously improve and deploy our technologically- advanced, cost-effective surgical robotic systems, while maintaining affordability and accessibility for the benefit of a larger segment of patients globally © 2026 SS INNOVATIONS INTERNATIONAL, INC. 3

  4. Slide 4: Snapshot of SS Innovations

    Snapshot of SS Innovations • We develop innovative, differentiated surgical robotic technologies, highlighted by our: 14,503 244 Multi-Specialty Surgeries SSi Mantra Systems Installed • Proprietary surgical robotic system, the SSi Mantra 3; • Comprehensive suite of surgical instruments, which 9 218

  5. Slide 5: Snapshot of SS Innovations (Continued)

    Snapshot of SS Innovations (Continued) Headquarters Gurugram, India Head & Neck Thoracic Company Domicile Florida, USA Gastrointestinal 148 135 Breast and Employees (June 30, 2026) 486 350 Plastic 15 Year Merged with Avra Medical 2023 Year Uplisted to Nasdaq 2025 Ticker SSII Cardiac 755 Exchange Nas

  6. Slide 6: Investment Highlights

    Investment Highlights 1• Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology 2• Large and Growing Total Addressable Market with Favorable Industry Tailwinds 3• Advanced, Cost-Efficient Surgical Robotics Platform – Clinically and Commercially Differentiated 4•

  7. Slide 7: Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology

    Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology Sudhir Srivastava, MD, Founder, Chairman & CEO Tim Paul Adams, Board Member • Robotic cardiac surgeon with 40+ years of experience • Regional Operating Officer, Ascension • Pioneered many of the world’s first

  8. Slide 8: Accelerated Global Adoption of Robotic Surgery

    Large and Growing Addressable Market with Favorable Industry Drivers Accelerated Global Adoption of Robotic Surgery Global Surgical Robotics Market1 Benefits of Robotic Surgery (in USD billions) Benefits to Patients CAGR • Smaller incisions, reduced trauma, less blood loss +14.7% • Less pain and dis

  9. Slide 9: Opportunity to Address Global Access

    Large and Growing Addressable Market with Favorable Industry Drivers Opportunity to Address Global Access Global Population1 Surgical Robotic Installed Base1 Greater than 90% of installed (% of total population) (% of total installations worldwide) surgical robotic systems are located in the US, EU

  10. Slide 10: Significant Market Opportunity in Our Foundational Market of India

    Large and Growing Addressable Market with Favorable Industry Drivers Significant Market Opportunity in Our Foundational Market of India More than 2,000 surgeons in India have been trained in robotic-assisted surgery, India United States including on the SSi Mantra. Population1 1.4 Billion 0.34 Billi

  11. Slide 11: SSi Mantra 3

    Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 2 2 Patient-Side Robotic Arm Carts 3 Vision Cart 3 Modular robotic arms mounted on individual carts with the option of 3D 4K resolution monitor, identical using 3, 4 or 5 robotic arm to the surgeon’s console, for OR configurations staf

  12. Slide 12: SSi Mantra 3 – Surgical Command Center

    Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Surgical Command Center Ergonomic Open-Faced Large 3D 4K Monitor Console Large 2D Touch Monitor Lightweight Magnetic for System Controls and Hand Controls Design DICOM access Head Tracking Digital Ergonomics Safety Feature Control Te

  13. Slide 13: SSi Mantra 3 – Patient Side Robotic Arm Carts

    Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Patient Side Robotic Arm Carts Modular Freedom of Robotic Carts Patient Docking 3/4/5 Absolute Stability Patient Cart Parking Locks Connectivity Smaller Individual Advanced Touch Cart Footprint Screen Controls © 2026 SS INNOVATIONS I

  14. Slide 14: SSi Mantra 3 – Vision Cart

    Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Vision Cart Inbuilt Multimedia Large 3D 4K Monitor Recording, Playback and for Operating Room Staff Streaming 3D 4k ICG Camera Pre-Operative Guidance System with 0- and 30- Software degree Endoscope UPS Backup E-Stop Safety Features

  15. Slide 15: SSi Mudra – Multi Specialty Robotic Instruments

    Advanced, Cost-Efficient Surgical Robotics Platform SSi Mudra – Multi Specialty Robotic Instruments 20+ 1 1 40+ 7 Degrees of Freedom 10 Use Cardiac Specialty Instruments Types of Articulating Robotic Life Cycle Only company in the world actively advocating for robotic cardiac surgery Instruments Ins

  16. Slide 16: SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI

    Advanced, Cost-Efficient Surgical Robotics Platform SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI Enabled Technologies SSi Guru AR Smart Glasses1 Cognitive Skill Simulator1 XR Tele Proctoring System 3D Visualization System A different approach to train surgeons • Mixed Reality

  17. Slide 17: Supported by the SS International Centre for Robotics Surgery

    Advanced, Cost-Efficient Surgical Robotics Platform Supported by the SS International Centre for Robotics Surgery (“SSICRS”) SS International Centre for Robotics Surgery • A premier educational institute for robotic-assisted surgical training • Subsidiary of SS Innovations • Located at the Company’s

  18. Slide 18: Pioneering Telesurgery Capabilities and Mobile Robotic Telesurgery Unit

    Advanced, Cost-Efficient Surgical Robotics Platform Pioneering Telesurgery Capabilities and Mobile Robotic Telesurgery Unit 195 telesurgeries have been completed with the SSi Mantra surgical robotic system2 Jul 2025 IRCAD HQ Sri Aurobindo IMS 4,000+ miles Strasbourg, France Indore, India May 2026 Sr

  19. Slide 19: The SSi MantrAsana Tele-Surgeon Console Facilitates Telesurgery from Anywhere

    Advanced, Cost-Efficient Surgical Robotics Platform The SSi MantrAsana Tele-Surgeon Console Facilitates Telesurgery from “Anywhere” SSi MantrAsana Tele-Surgeon Console Compact Self- Contained Chair Enables Portability Inbuilt Electronics Requires Less Space Magnetic Sensor- Based Controls Facilitate

  20. Slide 20: World-Class R&D and Manufacturing Facilities to Support Growth and Cost Efficiency

    Established Presence in India with Global Expansion Underway World-Class R&D and Manufacturing Facilities to Support Growth and Cost Efficiency Proximity to R&D, Manufacturing, New Delhi Assembly, and Operations International airport in Gurgaon, Delhi with excellent National Capital Region connectiv

  21. Slide 21: SSi Mantra 3 Is Demonstrating Rapid Adoption Across Various Geographies

    Established Presence in India with Global Expansion Underway SSi Mantra 3 Is Demonstrating Rapid Adoption Across Various Geographies Overview of Installed Base Cumulative Installed Base +113% 224 244 as of 9/28/26 105 As of 6/30/25 As of 6/30/26 Completed Procedures +164% 12,272 14,503 as of 9/28/26

  22. Slide 22: Global Expansion - Regulatory Approvals

    Established Presence in India with Global Expansion Underway Global Expansion - Regulatory Approvals India CDSCO Guatemala Indonesia Ecuador 2023 2023 2024 2024 Philippines Ukraine UAE Colombia 2025 2025 2025 2025 Oman Iraq Sri Lanka Kenya 2025 2025 2026 2026 Nepal Guyana US FDA EU CE 2026 2026 Anti

  23. Slide 23: Estimated Regulatory Timelines

    Established Presence in India with Global Expansion Underway Estimated Regulatory Timelines Current Stage US FDA 510(k) 510(k) Submitted AINN Received Clinical for Chole FDA Review / Response to FDA Q Sub Technical Multi-Specialty April 8, 2026 Indication and Market AINN 2024 Dossier Indications 180

  24. Slide 24: Strong Sales Growth with an Increasing Mix of Recurring Consumables Revenue and Expanding Margins

    Strong Sales Growth with an Increasing Mix of Recurring Consumables Revenue and Expanding Margins Revenue Revenue Mix Gross Margin ($ millions) (%) (%) +106% +507 bps $42.5 +2,858 bps 46.00% 40.93% +251% $42.5 mm $20.6 85% Revenue 15% 2025 12.35% $5.9 2023 2024 2025 2023 2024 2025 1 Systems Capital

  25. Slide 25: First Half 2026 – Robust Growth in Revenue and SSi Mantra Installations and Procedures

    First Half 2026 – Robust Growth in Revenue and SSi Mantra Installations and Procedures Revenue SSi Mantra Installations SSi Mantra Procedures ($ millions) (# of systems) (# of surgeries) +47% +136% +66% 56 $25.0 4,387 38 $15.1 1,861 1H'25 1H'26 1H'25 1H'26 1H'25 1H'26 © 2026 SS INNOVATIONS INTERNATI

  26. Slide 26: Growth Strategy

    Growth Strategy Target Leading Surgeons and Thought Platform Focus on Large Leaders to Raise Awareness and Value Multi-Specialty Hospitals Encourage Widespread Adoption • Advanced Technology • Secure Initial Placements • Indian Medical Advisory Board • Lower Cost • Expand # of Physicians using Mantr

  27. Slide 27: Appendix

    Appendix © 2026 SS INNOVATIONS INTERNATIONAL, INC. 27

  28. Slide 28: Financial Summary

    Financial Summary SS Innovations Twelve Months Ended Six Months Ended Three Months Ended Statement of Operations (in USD) Dec. 31, 2023 Dec. 31, 2024 Dec. 31, 2025 June 30, 2025 June 30, 2026 June 30, 2025 June 30, 2026 Revenue 5,875,314 20,649,528 42,484,747 15,120,915 25,041,075 10,000,305 13,939,

  29. Slide 29: Summary of SSi Mantra Installations

    Summary of SSi Mantra Installations Annual Installations Quarterly Installations Year # Growth Year # Growth 103 Q1’24 9 - 2022 3 - Q2’24 10 - 2023 15 400% 47 Q3’24 6 - 2024 47 213% 15 3 Q4’24 22 - 38 2025 103 119% 2022 2023 2024 2025 Q1’25 15 67% Q2’25 23 130% 30 Q3’25 27 350% 27 26 Q4’25 38 73% 23

  30. Slide 30: Investor Contact

    Investor Contact: Kalle Ahl, CFA (303) 953-9878 kalle.ahl@theequitygroup.com www.ssinnovations.com investors@ssinnovations.org © 2026 SS INNOVATIONS INTERNATIONAL, INC. 30

SS Innovations International — Investor Presentation (October 2026) on 6ix